Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - OtherShares IssuedShares OutstandingShares OutstandingWages, Salaries and Other
Ratios

Bicycle Therapeutics (BCYC) Shares Issued (2019 - 2026)

Bicycle Therapeutics (BCYC) has disclosed Shares Issued for 8 consecutive years, with $12000.0 as the latest value for Q1 2026.

  • For Q1 2026, Shares Issued rose 500.0% year-over-year to $12000.0; the TTM value through Mar 2026 reached $47000.0, down 99.17%, while the annual FY2025 figure was $37000.0, 99.51% down from the prior year.
  • Shares Issued hit $12000.0 in Q1 2026 for Bicycle Therapeutics, down from $33000.0 in the prior quarter.
  • Across five years, Shares Issued topped out at $19.4 million in Q3 2023 and bottomed at -$248.7 million in Q4 2023.
  • Average Shares Issued over 5 years is -$12.0 million, with a median of $195000.0 recorded in 2022.
  • Year-over-year, Shares Issued crashed 5175.59% in 2023 and then surged 93450.0% in 2024.
  • Bicycle Therapeutics' Shares Issued stood at $4.9 million in 2022, then plummeted by 5175.59% to -$248.7 million in 2023, then surged by 100.1% to $245000.0 in 2024, then tumbled by 86.53% to $33000.0 in 2025, then crashed by 63.64% to $12000.0 in 2026.
  • According to Business Quant data, Shares Issued over the past three periods came in at $12000.0, $33000.0, and $1000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.